EUVIMEDEUVIMED entdecken
Open Access

Enhanced hypoxia resistance distinguishes human pluripotent stem cell-derived islets from primary islets

Hiroyuki Kato iD, Kuang-Ming Shang iD, Hiroaki Mitsugashira iD, Meirigeng Qi, Tomoharu Suzuki, Peter G Stock iD, Taro Toyoda iD, Yu-Chong Tai, Fouad Kandeel, Hirotake Komatsu iD

American Journal of Physiology-Cell Physiology · 2026

DOI: 10.1152/ajpcell.00043.2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2026. Verfasst von Hiroyuki Kato und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transplant Surgery, Department of Surgery, University of California, San Francisco, California, United States. Hauptthemen laut MEDLINE: Islets of Langerhans, Oxygen, Pluripotent Stem Cells, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Breakthrough T1D (JDF), Nora Eccles Treadwell Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study provides the first quantitative evidence that human stem cell-derived islets are more resistant to hypoxia than primary human islets. Stem cell-derived islets maintain viability at substantially lower oxygen levels and exhibit markedly reduced variability in hypoxia tolerance. These findings identify hypoxia resistance as a key functional advantage of stem cell-derived islets, with important implications for transplantation into low-oxygen environments and for scalable islet fabrication strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Islets of LangerhansOxygenPluripotent Stem CellsInduced Pluripotent Stem CellsHumansCell HypoxiaCells, CulturedCell SurvivalIslets of Langerhans TransplantationCell DifferentiationSpheroids, Cellular

Stichwörter der Autor:innen

graft survivalhuman primary pancreatic isletshuman stem cell-derived isletshypoxia resistanceoxygen tension

Substanzen

Oxygen

Autor:innen und Institutionen

  • Division of Transplant Surgery, Department of Surgery, University of California, San Francisco, California, United States.
  • Department of Medical Engineering, California Institute of Technology, Pasadena, California, United States.
  • Department of Translational Research & Cellular Therapeutics, Arthur Riggs Diabetes & Metabolism Research Institute of City of Hope, Duarte, California, United States.
  • Department of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.

ORCID-Profile: Hiroyuki Kato, Kuang-Ming Shang, Hiroaki Mitsugashira, Peter G Stock, Taro Toyoda, Hirotake Komatsu

Förderung

  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Breakthrough T1D (JDF)
  • Nora Eccles Treadwell Foundation
  • NIDDK NIH HHS

Zitieren

APA

Kato, H., Shang, K. M., Mitsugashira, H., Qi, M., Suzuki, T., Stock, P. G., Toyoda, T., Tai, Y. C., Kandeel, F., & Komatsu, H. (2026). Enhanced hypoxia resistance distinguishes human pluripotent stem cell-derived islets from primary islets. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00043.2026

Vancouver

Kato H, Shang KM, Mitsugashira H, Qi M, Suzuki T, Stock PG, et al. Enhanced hypoxia resistance distinguishes human pluripotent stem cell-derived islets from primary islets. American Journal of Physiology-Cell Physiology. 2026. doi:10.1152/ajpcell.00043.2026

BibTeX
@article{Kato2026,
  author = {Kato, Hiroyuki and Shang, Kuang-Ming and Mitsugashira, Hiroaki and Qi, Meirigeng and Suzuki, Tomoharu and Stock, Peter G and Toyoda, Taro and Tai, Yu-Chong and Kandeel, Fouad and Komatsu, Hirotake},
  title = {Enhanced hypoxia resistance distinguishes human pluripotent stem cell-derived islets from primary islets},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2026},
  doi = {10.1152/ajpcell.00043.2026}
}
Kostenlos starten →